Stephen Smolinski
2022 - Avalo Therapeutics
In 2022, Stephen Smolinski earned a total compensation of $990.9K as Former Chief Commercial Officer at Avalo Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $11,573 |
|---|---|
| Option Awards | $489,947 |
| Salary | $74,242 |
| Other | $415,117 |
| Total | $990,879 |
Smolinski received $489.9K in option awards, accounting for 49% of the total pay in 2022.
Smolinski also received $11.6K in non-equity incentive plan, $74.2K in salary and $415.1K in other compensation.
Rankings
In 2022, Stephen Smolinski's compensation ranked 3,056th out of 5,760 executives tracked by ExecPay. In other words, Smolinski earned more than 46.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,056 out of 5,760 | 47th |
Division Manufacturing | 1,718 out of 3,136 | 45th |
Major group Chemicals And Allied Products | 807 out of 1,422 | 43rd |
Industry group Drugs | 753 out of 1,323 | 43rd |
Industry Pharmaceutical Preparations | 547 out of 969 | 44th |
Source: SEC filing on October 19, 2023.
Smolinski's colleagues
We found three more compensation records of executives who worked with Stephen Smolinski at Avalo Therapeutics in 2022.